Ad break

AstraZeneca highlights a $50 billion U.S. investment in manufacturing and R&D and its commitment to medicines.

Play episode from 06:47

Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!